capsule (pharmacologic) – Talk Bio

Actionable Insights Powered by AI

CDMO Pulse Check: Lonza Posts Major Sales Rebound as Samsung Bio Keeps Revenue Growth Rolling

2 days ago talkbio0Tagged capsule (pharmacologic), CDMO, commercial, expansion, Growth, Lonza, Manufacturing, profit margin, Sales - occupational activity, Samsung Bio

Lonza; CDMO; sales growth; Samsung Bio; 2025 outlook; profit margin; Capsules & Health Ingredients; commercial momentum; manufacturing expansion

Lonza Expands Gelatin Capsule Production in India and China Amid Plans to Exit Capsules Business

7 months ago talkbio0Tagged capsule (pharmacologic), China, Exit Strategy, expansion, gelatin, India, Lonza

Lonza, Capsules & Health Ingredients, Gelatin Capsules, India, China, Expansion, Exit Strategy

Lonza Announces Strategic Shift to Focus on CDMO Business, Exits Capsules & Health Ingredients

8 months ago talkbio0Tagged capsule (pharmacologic), CDMO, Lonza, restructure

Lonza, CDMO, Capsules & Health Ingredients, Restructure, One Lonza Strategy